Drug repurposing of fluoroquinolones as anticancer agents in 2023
RSC Advances · 2024 · 14 (50) · 37114-37130
DOI: 10.1039/d4ra03571b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2024. Verfasst von Asmaa E Kassab und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University Kasr El-Aini Street, P. O. Box 11562 Cairo Egypt. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Drug developers are currently focusing on investigating alternative strategies, such as “drug repositioning”, to address issues associated with productivity, regulatory obstacles, and the steadily rising cost of pharmaceuticals.
Autor:innen und Institutionen
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University Kasr El-Aini Street, P. O. Box 11562 Cairo Egypt.
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University P. O. Box 35516 Mansoura Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Industries, Badr University in Cairo (BUC) Badr City, P. O. Box 11829 Cairo Egypt asmaa.kassab@pharma.cu.edu.eg +2023635140 +2023639307.
ORCID-Profile: Asmaa E Kassab
Zitieren
APA
Kassab, A. E., Gomaa, R. M., & Gedawy, E. M. (2024). Drug repurposing of fluoroquinolones as anticancer agents in 2023. RSC Advances, 14(50), 37114-37130. https://doi.org/10.1039/d4ra03571b
Vancouver
Kassab AE, Gomaa RM, Gedawy EM. Drug repurposing of fluoroquinolones as anticancer agents in 2023. RSC Advances. 2024;14(50):37114-37130. doi:10.1039/d4ra03571b
BibTeX
@article{Kassab2024,
author = {Kassab, Asmaa E and Gomaa, Rania M and Gedawy, Ehab M},
title = {Drug repurposing of fluoroquinolones as anticancer agents in 2023},
journal = {RSC Advances},
year = {2024},
volume = {14},
number = {50},
pages = {37114--37130},
doi = {10.1039/d4ra03571b}
}
EUVIMED